Fifteen U.S. congressmen sent a letter to U.S. Attorney General Jeff Sessions and Drug Enforcement Administration (DEA) Acting Administrator Uttam Dhillon expressing dismay at DEA’s plans to import Canadian marijuana.
The letter also chides the Trump Administration for not approving the applications of addition marijuana manufacturers, despite its “Buy America” campaign:
“Considering the recent decision by the Drug Enforcement Administration (DEA) to approve the importation from Canada of marijuana for research, we write with deep concern and with questions over the delay in approving addition approved domestic manufacturers of cannabis for this same purpose.”
“On April 18, 2017, President Trump issued an executive order to ‘Buy American and Hire American.’ Despite the Department of Justice (DOJ) and DEA possessing over two dozen applications from qualified domestic manufacturers, however, DEA approved the importation of cannabis products from Canada.
“Adding insult to injury, one application to produce research cannabis was submitted by a campus within the University of California system – and one campus of that system will be the eventual recipient of Tilray, Inc.’s THC and CBD products.”
The letter urges the Trump Administration to set and reveal a plan for the approval of more domestic pot-producing plants, and offers to support those efforts:
“We look forward to working with the Administration to see that our domestic need for cannabis for research can be met with American institutions.”
The letter, embedded below, was posted Monday on the Facebook page of Rep. Eric Swalwell (D-Calif.), whose signature, along with that of Rep. Matt Gaetz (R-Fla.), tops the 15 signatures.